IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 139
Titolo Data di pubblicazione Autore(i) File
ERYTHROPOIETIN (EPO) BLOOD CONCENTRATION IN PATIENTS WITH SOLID TUMOR-INDUCED BONE MARROW INFILTRATION 1-gen-2004 Frontini, L; Lissoni, P; Vaghi, M; Ardizzoia, A; Pressiani, T; Simonelli, M; Colombo, I; Stabilini, R; Gardani, G
MODULATION OF IL-2 CANCER IMMUNOTHERAPY BY CYCLOOXYGENASE (COX)-2 INHIBITORS: THERAPEUTIC AND BIOLOGICAL RESULTS OF IL-2 PLUS CELECOXIB IN METASTATIC RENAL CELL CANCER (RCC) PROGRESSING ON IL-2 ALONE 1-gen-2004 Lissoni, P; Vaghi, M; Frontini, L; Ardizzoia, A; Pressiani, T; Colombo, I; Simonelli, M; Gardani, G
Three-day low-dose Cisplatin administration in advanced non-small cell lung cancer (NSCLC): Efficacy and reduced toxicity 1-gen-2004 Frontini, L; Ardizzoia, A; Pressiani, T; Colombo, I; Simonelli, M; Vaghi, M; Lissoni, P; Gardani, G
Herpes infections in breast cancer patients treated with adjuvant chemotherapy 1-gen-2006 Masci, G; Magagnoli, M; Gullo, G; Morenghi, E; Garassino, I; Simonelli, M; Santoro, A
Optimizing residual surgery for patients with primary extragonadal germ cell tumors 1-gen-2006 Simonelli, M; Banna, Gl; De Giorgi, U; Ferrari, B; Alloisio, M; Incarbone, M; Chiti, A; Rosti, G; Santoro, A
High incidence of hypocalcemia in patients with bone metastases from different kinds of neoplasms, treated with zoledronate 1-gen-2006 Zuradelli, M; Masci, G; Tronconi, Mc; Rimassa, L; Gullo, G; Pressiani, T; Simonelli, M; Morenghi, E; Biancofiore, G; Santoro, A
Reliability of the HER2 status assessment by immunohistochemistry for breast cancer patients after preoperative chemotherapy 1-gen-2006 Banna, Gl; Gulio, G; Masci, G; Simonelli, M; Rimassa, L; Di Tommaso, L; Bettio, D; Roncalli, M; Santoro, A
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme 1-gen-2007 Banna, Gl; Bettio, D; Scorsetti, M; Navarria, P; Simonelli, M; Baena Riccardo, R; Aimar, E; Gaetani, P; Colombo, Pg; Rognone, F; Santoro, A
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 1-gen-2007 Simonelli, M; Tadayyon, S; Banna, Gl; De Giorgi, U; Alloisio, M; Santoro, A; Chiti, A
High-dose chemotherapy followed by autologous hematopoietic stem-cell transplantation for the treatment of solid tumors in adults: a critical review 1-gen-2007 Banna, Giuseppe Luigi; Simonelli, Matteo; Santoro, Armando
Electrolyte abnormalities and side effects of zoledronate in patients with bone metastases 1-gen-2008 Zuradelli, M; Masci, G; Biancofiore, G; Gullo, G; Simonelli, M; Scorsetti, M; Baena, Rry; Berlusconi, M; Morenghi, E; Santoro, A
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas 1-gen-2009 Simonelli, M; Banna, G; Navarria, P; Di Ieva, A; Zucali, P; De Vincenzo, F; Gaetani, P; Condorelli, R; Baena, Rry; Scorsetti, M; Santoro, A
Thymoma associated with myasthenia and autonomic anti-Hu paraneoplastic neuropathy 1-gen-2009 Simonelli, M; Banna, Gl; Santoro, A
Future developments in the management of malignant pleural mesothelioma 1-gen-2009 Zucali, Pa; De Vincenzo, F; Simonelli, M; Santoro, A
THE ROLE OF THYMIDTYLATE SYNTHASE (TS) AND EXCISION REPAIR CROSS-COMPLEMENTING GROUP 1 (ERCC1) IMMUNOHISTOCHEMICAL EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) PATIENTS TREATED WITH PEMETREXED AND CARBOPLATIN 1-gen-2009 Zucali, Pa; Destro, A; Ceresoli, Gl; Gianoncelli, L; Lorenzi, E; De Vincenzo, F; Simonelli, M; Giordano, L; Roncalli, M; Santoro, A
The role of thymidylate synthase (TS) and excision repair cross-complementing group 1 (ERCC1) immunohistochemical expression in malignant pleural mesothelioma patients treated with pemetrexed and carboplatin 1-gen-2009 Zucali, P; Destro, A; Ceresoli, Gl; Gianoncelli, L; Lorenzi, E; De Vincenzo, F; Simonelli, M; Giordano, L; Roncalli, M; Santoro, A
Phase II Study of Asparagine-Glycine-Arginine-Human Tumor Necrosis Factor alpha, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma 1-gen-2010 Gregorc, V; Zucali, PAOLO ANDREA; Santoro, A; Ceresoli, G L; Citterio, G; De Pas T, M.; Zilembo, N; De Vincenzo, F; Simonelli, M; Rossoni, G; Spreafico, A; Vigano, M G; Fontana, F; De Braud, F G; Bajetta, E; Caligaris-Cappio, F; Bruzzi, P; Lambiase, A; Bordignon, C
Retreatment with pemetrexed-based chemotherapy (PBC) in patients with malignant pleural mesothelioma (MPM): An observational study 1-gen-2010 De Vincenzo, F; Zucali, P; Ceresoli, G; Gianoncelli, L; Lorenzi, E; Simonelli, M; Ripa, C; Giordano, L; Santoro, A
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy 1-gen-2010 Prognostic Factors Study Group, International; Simonelli, M; Zucali, P; Lorch, Anja; Beyer, Jörg; Bascoul-Mollevi, Caroline; Kramar, Andrew; H Einhorn, Lawrence; Necchi, Andrea; Massard, Christophe; De Giorgi, Ugo; Fléchon, Aude; A Margolin, Kim; Lotz, Jean-Pierre; Ramon Germa Lluch, Jose; Powles, Thomas; K Kollmannsberger, Christian
VINORELBINE (V) IN PEMETREXED-PRETREATED PATIENTS (PTS) WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) 1-gen-2010 De Vincenzo, F; Lorenzi, E; Zucali, Pa; Simonelli, M; Gianoncelli, L; Ceresoli, Gl; Ripa, C; Giordano, L; Santoro, A
Mostrati risultati da 1 a 20 di 139
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile